Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-03-05 @ 10:02 PM
Study NCT ID:
NCT03804567
Status:
COMPLETED
Last Update Posted:
2020-04-10
First Post:
2019-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oldpain2go®: an Exploratory (Pre-Feasibility) Study.
Sponsor:
Teesside University
Organization:
Study Overview
Official Title:
Oldpain2go®: an Exploratory (Pre-Feasibility) Study.
Status:
COMPLETED
Status Verified Date:
2020-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Oldpain2go®
Brief Summary:
Research question: Is there any evidence to suggest that the oldpain2go® intervention merits scientific investigation?
Detailed Description:
Aims:
1. To collect data to:
1. give an indication of the potential effect size, of any effects, from the oldpain2go® intervention, in people with persistent low back pain.
2. to explore the eligibility criteria, recruitment methods and materials proposed here, for potential use in a future Feasibility study, of the oldpain2go® intervention.
2. To compare demographic characteristics, medical history and outcome measure data of:
1. people for whom Oldpain2go® is indicated (at the Oldpain2go® screening session), with those for whom it is not,
2. people for whom the Oldpain2go® intervention works, after one treatment, with those for whom it does not, and
3. people for whom the Oldpain2go® intervention works, after one, or two, treatments, with those for whom it does not work after two treatments.
1. To collect data to:
1. give an indication of the potential effect size, of any effects, from the oldpain2go® intervention, in people with persistent low back pain.
2. to explore the eligibility criteria, recruitment methods and materials proposed here, for potential use in a future Feasibility study, of the oldpain2go® intervention.
2. To compare demographic characteristics, medical history and outcome measure data of:
1. people for whom Oldpain2go® is indicated (at the Oldpain2go® screening session), with those for whom it is not,
2. people for whom the Oldpain2go® intervention works, after one treatment, with those for whom it does not, and
3. people for whom the Oldpain2go® intervention works, after one, or two, treatments, with those for whom it does not work after two treatments.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: